A Nano-MgO and Ionic Liquid-Catalyzed ‘Green’ Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51)

Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma

(2015) Mahabaleshwaraiah Neelgundmath et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Microwave-assisted synthesis, characterization and cytotoxic studies of novel estrogen receptor α ligands towards human breast cancer cells

(2015) Hanumantharayappa Bharathkumar et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Drug-resistance mechanisms and tuberculosis drugs

(2015) Claudio U Köser et al.   LANCET

Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis

(2014) Dinesh Addla et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

MgO nanoparticles as antibacterial agent: preparation and activity

(2014) Zhen-Xing Tang et al.   BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING

Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis

(2014) Roman Šink et al.   JOURNAL OF MEDICINAL CHEMISTRY

A New Ibuprofen Derivative Inhibits Platelet Aggregation and ROS Mediated Platelet Apoptosis

(2014) Kodagahalli S. Rakesh et al.   PLoS One

Synthesis and Characterization of Novel 2-Amino-Chromene-Nitriles that Target Bcl-2 in Acute Myeloid Leukemia Cell Lines

(2014) Hosadurga K. Keerthy et al.   PLoS One

The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives

(2013) Lukas Wanka et al.   CHEMICAL REVIEWS

In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori

(2013) Morris O. Makobongo et al.   PLoS One

Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability

(2012) Michael S. Scherman et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Synthesis, Biological Evaluation, and Structure-activity Relationship of Clonazepam, Meclonazepam, and 1,4-Benzodiazepine Compounds with Schistosomicidal Activity

(2012) Carla M. S. Menezes et al.   Chemical Biology & Drug Design

EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole

(2012) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials

(2012) I. Balderas-Renteria et al.   CURRENT MEDICINAL CHEMISTRY

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

(2012) Katherine A Sacksteder et al.   Future Microbiology

ShelXle: a Qt graphical user interface forSHELXL

(2011) Christian B. Hübschle et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

Design of the Anti-tuberculosis Drugs induced Adverse Reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS)

(2010) Yin Yin Xia et al.   BMC PUBLIC HEALTH

Nano-MgO: An Efficient Catalyst for the Synthesis of Formamides from Amines and Formic Acid Under MWI

(2010) M. B. Madhusudana Reddy et al.   CATALYSIS LETTERS

Structure validation in chemical crystallography

(2009) Anthony L. Spek   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit

(2009) Chiung-Kuang Chen et al.   PLoS Neglected Tropical Diseases

Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures

(2008) Paul Labute   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug

(2004) Lee Jia et al.   BRITISH JOURNAL OF PHARMACOLOGY